This inventor holds 3 USPTO granted patents. Top assignee: Incyte Corporation. Active years: 2006-2014.
Company Filing History:
Years Active: 2006-2014
Title: Michael Jason Bower: Innovator in Kinase Inhibitors
Introduction
Michael Jason Bower is a prominent inventor based in Newark, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic compounds that serve as kinase inhibitors. With a total of 3 patents to his name, Bower's work is instrumental in addressing various medical conditions.
Latest Patents
Bower's latest patents focus on macrocyclic compounds and their applications as kinase inhibitors. These compounds are designed to target JAK/ALK pathways, which are crucial in the treatment of diseases associated with inflammation, autoimmune disorders, and cancer. The innovative formulations include pharmaceutically acceptable salts and quaternary ammonium salts, enhancing their therapeutic potential.
Career Highlights
Michael Jason Bower is currently associated with Incyte Corporation, a leading biopharmaceutical company. His role involves extensive research and development aimed at creating effective treatments for complex diseases. Bower's expertise in medicinal chemistry and his dedication to innovation have positioned him as a key player in his field.
Collaborations
Throughout his career, Bower has collaborated with talented professionals, including Andrew Paul Combs and Wenyu Zhu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Michael Jason Bower's contributions to the field of kinase inhibitors exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new treatments that can significantly improve patient outcomes.